RASBURICASE News
RASBURICASE currently has 0 news articles, with 11 predicted indications.
This page combines the AI-predicted indications for RASBURICASE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (11):
- obsolete hyperuricemia (disease) (99.0%)
- hypouricemia, renal (100.0%)
- hypoxanthine guanine phosphoribosyltransferase partial deficiency (100.0%)
- hepatic porphyria (100.0%)
- hepatopulmonary syndrome (100.0%)
- early-onset familial noncirrhotic portal hypertension (100.0%)
- idiopathic copper-associated cirrhosis (100.0%)
- primitive portal vein thrombosis (100.0%)
- hepatoportal sclerosis (100.0%)
- renal tubular acidosis (99.8%)
- disorder of phenylalanine metabolism (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.